Table 3.
TGF-β | Acute phase (n = 39) | One week follow-up (n = 29) | p-value |
---|---|---|---|
TGF-β1 (ng/ml; mean ± SD) | 74 ± 28 | 89 ± 39 | 0.020 |
TGF-β1 (ng/ml; median) | 74 | 86 | 0.020 |
TGF-β2 (pg/ml; mean ± SD) | 479 ± 146 | 533 ± 118 | 0.008 |
TGF-β2 (pg/ml; median) | 488 | 534 | 0.008 |
TGF-β1/Cr (mean ± SD) | 17 ± 10 | 37 ± 40 | 0.020 |
TGF-β1/Cr (median) | 13 | 22 | 0.020 |
TGF-β2/Cr (mean ± SD) | 110 ± 68 | 212 ± 197 | 0.008 |
TGF-β2/Cr (median) | 88 | 117 | 0.008 |
Cr: creatinine